Mannose-binding lectin 2 (Mbl2) gene polymorphisms are related to protein plasma levels, but not to heart disease and infection by Chlamydia

The presence of the single nucleotide polymorphisms in exon 1 of the mannose-binding lectin 2 (MBL2) gene was evaluated in a sample of 159 patients undergoing coronary artery bypass surgery (71 patients undergoing valve replacement surgery and 300 control subjects) to investigate a possible association between polymorphisms and heart disease with Chlamydia infection. The identification of the alleles B and D was performed using real time polymerase chain reaction (PCR) and of the allele C was accomplished through PCR assays followed by digestion with the restriction enzyme. The comparative analysis of allelic and genotypic frequencies between the three groups did not reveal any significant difference, even when related to previous Chlamydia infection. Variations in the MBL plasma levels were influenced by the presence of polymorphisms, being significantly higher in the group of cardiac patients, but without representing a risk for the disease. The results showed that despite MBL2 gene polymorphisms being associated with the protein plasma levels, the polymorphisms were not enough to predict the development of heart disease, regardless of infection with both species of Chlamydia.

Polymorphism in the promoter region of the mannose-binding lectin gene among human T-cell lymphotropic virus infected subjects

The present study investigated the frequency of the mutations at positions -550 and -221 of the mannose-binding lectin (MBL) gene in a sample of 75 human T-cell lymphotropic virus (HTLV) infected patients and 96 HTLV seronegative controls, in order to evaluate the occurrence of a possible association between the polymorphism and HTLV infection. A sequence specific primer-polymerase chain reaction was used for discrimination of the polymorphism. The analysis of allele frequencies at position -550 did not show any significant differences between HTLV infected group and controls, but there was a significant difference at position -221. The comparative analysis of haplotypes frequencies were not significant, but the genotype frequencies between the two groups, revealed a higher prevalence of genotype LYLX (25.3 percent), associated with medium and low MBL serum levels among HTLV infected subjects. The odds ratio estimation demonstrated that the presence of genotype LYLX was associated with an increased risk of HTLV infection (p = 0.0096; 1.38 < IC95 percent < 7.7605). There was no association between proviral load and the promoter polymorphism, but when promoter and exon 1 mutations were matched, it was possible to identify a significant higher proviral load among HTLV infected individuals carrying haplotypes correlated to low serum levels of MBL. The present study shows that the polymorphism in the promoter region of the MBL gene may be a genetic marker associated with HTLV infection, and emphasizes the need for further studies to determinate if the present polymorphism have any impact on diseases linked to HTLV infection.

Identification of human T-cell lymphotropic virus infection in a semi-isolated Afro-Brazilian quilombo located in the Marajó Island (Pará, Brazil)

Antibodies to human T-cell lymphotropic virus-1 and 2 (HTLV-1 and 2) were tested in 259 inhabitants (98 males and 161 females) of four villages of the Marajó Island (Pará, Brazil) using enzyme immunoassays (ELISA and Western blot). Types and subtypes of HTLV were determined by nested polymerase chain reaction (PCR) targeting the pX, env and 5 LTR regions. HTLV-1 infection was detected in Santana do Arari (2.06 percent) and Ponta de Pedras (1 percent). HTLV-2 was detected only in Santana do Arari (1.06 percent). Sequencing of the 5 LTR region of HTLV-1 and the phylogenetic analysis identified the virus as a member of the Cosmopolitan Group, subgroup Transcontinental. Santana do Arari is an Afro-Brazilian community and the current results represent the first report of HTLV-1 infection in a mocambo located in the Brazilian Amazon region.

Molecular characterization of human T-cell lymphotropic virus coinfecting human immunodeficiency virus 1 infected patients in the Amazon region of Brazil

The present work evaluated the epidemiology of human immunodeficiency virus 1/human T-cell lymphotropic virus (HIV-1/HTLV) coinfection in patients living in Belém (state of Pará) and Macapá (state of Amapá), two cities located in the Amazon region of Brazil. A total of 169 blood samples were collected. The sera were tested by enzyme-linked immunosorbent assay to determine the presence of antibodies anti-HTLV-1/2. Confirmation of infection and discrimination of HTLV types and subtypes was performed using a nested polymerase chain reaction targeting the pX and 5' LTR regions, followed by restriction fragment length polymorphism and sequencing analysis. The presence of anti-HTLV1/2 was detected in six patients from Belém. The amplification of the pX region followed by RFLP analysis, demonstrated the presence of HTLV-1 and HTLV-2 infections among two and four patients, respectively. Sequencing HTLV-1 5' LTR indicated that the virus is a member of the Cosmopolitan Group, Transcontinental subgroup. HTLV-2 strains isolated revealed a molecular profile of subtype HTLV-2c. These results are a reflex of the epidemiological features of HIV-1/HTLV-1/2 coinfection in the North region of Brazil, which is distinct from other Brazilian regions, as reported by previous studies.

Serological evidence of HTLV-I and HTLV-II coinfections in HIV-1 positive patients in Belém, State of Pará, Brazil

The occurence of HTLV-I/II and HIV-1 coinfections have been shown to be frequent, probably in consequence of their similar modes of transmission. This paper presents the prevalence of coinfection of HTLV among HIV-1 infected and AIDS patients in Belém, State of Pará, Brazil. A group of 149 patients attending the AIDS Reference Unit of the State Department of Health was tested for the presence of antibodies to HTLV-I/II using an enzyme immunoassay and the positive reactions were confirmed with a Western blot that discriminates between HTLV-I and HTLV-II infections. Four patients (2.7 per cent) were positive to HTLV-I, seven (4.7 per cent) to HTLV-II and one (0.7 per cent) showed an indeterminate pattern of reation. The present results show for the first time in Belém not only the occurrence of HTLV-II/HIV-1 coinfections, but also a higher prevalence of HTLV-II in relation to HTLV-I. Furthermore. it also enlarges the geographical limits of the endemic area for HTLV-II in the Amazon region of Brazil.

A possible correlation between the host genetic background in the epidemiology of hepatitis B virus in the Amazon region of Brazil

The Amazon region of Brazil is an area of great interest because of the large distribution of hepatitis B virus in specific Western areas. Seven urban communities and 24 Indian groups were visited in a total of 4,244 persons. Each individual was interviewed in order to obtain demographic and familial information. Whole blood was collected for serology and genetic determinations. Eleven genetic markers and three HBV markers were tested. Among the most relevant results it was possible to show that (i) there was a large variation of previous exposure to HBV in both urban and non-urban groups ranging from 0 to 59.2 por cento; (ii) there was a different pattern of epidemiological distribution of HBV that was present even among a same linguistic Indian group, with mixed patterns of correlation between HBsAg and anti-HBs and (iii) the prevalence of HBV markers (HBsAg and anti-HBs) were significantly higher (P=0.0001) among the Indian population (18.8 por cento) than the urban groups (12.5 por cento). Its possible that the host genetic background could influence and modulate the replication of the virus in order to generate HB carrier state.

Avaliaçåo de um teste de aglutinaçåo de partículas de gelatina para a detecçåo de anticorpos anti-HIV-1 / Evaluation of the gelatin particle agglutination test for the detection of anti-HIV-1 antibodies

Um total de 200 amostras de soro, obtidas de um hemocentro (HEMOPA), foram testadas através de ensaio imunoenzimático comercial (ELISA) para detecçåo de anticorpos anti-HIV-1 e comparadas com um teste de aglutinaçåo de partículas de gelatina (SERODIA HIV-1/FUJIREBIO). Os resultados mostraram uma concordância de 99,5 por cento. A sensibilidade e a especificidade foram de 100 por cento e 99,5 por cento, respectivamente. Nåo houve amostra com resultados falso negativos e apenas um soro foi falso positivo. O teste de aglutinaçåo de partículas de gelatina oferece vantagens que incluem simplicidade e rapidez na execuçåo e baixo custo. O teste SERODIA HIV-1 é recomendado para procedimentos de triagem de anticorpos para o HIV-1 em hemocentros e laboratórios envolvidos com diagnóstico e pesquisa

Soroepidemiologia retrospectiva do HIV-1 / Retrospective seroepidemiology of HIV-1

Amostras de soro de grupos populacionais dos Estados do Pará e Goiás, coletados ente 1974 e 1980, foram testadas (ELISA, imunofluorescência e immunoblot) para a presença de anticorpos contra o vírus da imunodeficiência humana tipo-1 (HIV-1). O objetivo principal foi de se mapear epidemiologicamente a ocorrência deste vírus em um período anterior a detecçäo da presente epidemia. Quatro amostras dos índios Xicrin foram positivas pelo teste ELISA, porém näo foram confirmadas pelos demais testes. Os resultados negativos sugerem a ausência de circulaçäo do HIV-1, nos grupos testados, no período pré-1980

Biossegurança no laboratório / Biosafety in the laboratory

Nos últimos dez anos tem sido travada uma luta com a finalidade de prevenir a transmissäo de agentes infecciosos dentro de laboratórios. A grande fonte de dispersäo de patógenos por meio de aerossóis, pode ser eliminada satisfatoriamente com o uso de câmaras de segurança biológica. Regras gerais e específicas de biossegurança devem ser cumpridas por todos os usuários de laboratórios que manuseiam patógenos ou materiais potencialmente contaminantes e, eventualmente, avaliados por um comitê de biossegurança independente. O surgimento da síndrome de imunodeficiência adquirida deve servir como fator de estímulo à adoçäo de normas eficazes de segurança laboratorial